- Report
- May 2024
- 135 Pages
Global
From €5712EUR$6,499USD£4,941GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4351EUR$4,950USD£3,763GBP
- Report
- April 2024
- 185 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- August 2022
- 376 Pages
Global
From €2197EUR$2,500USD£1,901GBP
- Report
- November 2023
- 109 Pages
Global
From €3500EUR$4,266USD£3,133GBP
The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more